|Bid||23.96 x 0|
|Ask||24.08 x 0|
|Day's Range||23.25 - 24.88|
|52 Week Range||4.05 - 24.88|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
TORONTO, Jan. 15, 2018-- Scythian Biosciences Corp. is pleased to announce that Mr. George Scorsis, the Chief Executive Officers of both Aphria Inc. and Liberty Health Sciences Inc., respectively, are ...
TORONTO, Jan. 10, 2018-- Scythian Biosciences Corp. is pleased to announce that it has been upgraded to the OTCQB Marketplace as of January 10, 2018 and will be traded under the symbol“ SCCYF”.. “We look ...
TORONTO, Jan. 04, 2018-- Scythian Biosciences Corp. announces that its Board of Directors has approved a proposed up to eight for one stock split of its outstanding common shares. The stock split is subject ...
TORONTO, Dec. 28, 2017-- Scythian Biosciences Corp. is issuing this press release in response to a request by the Investment Industry Regulatory Organization of Canada to comment on recent trading activity ...
TORONTO, Dec. 11, 2017-- Scythian Biosciences Corp. is pleased to announce that it has appointed Ottis Jerome“ O.J.” Anderson to its Pro Athlete Advisory Committee.. “We are proud to introduce Mr. Ottis ...
TORONTO, Nov. 30, 2017-- Scythian Biosciences Corp. is pleased to announce that it has entered into a share purchase agreement with 1065703 B.C. Ltd. to sell to the Purchaser its wholly-owned subsidiary ...